Healthcare - Biotechnology - NASDAQ - US
$ 12.56
-7.58 %
$ 165 M
Market Cap
-15.9
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
100.00%
Net Income
Estimate
--18.49%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Greenwich LifeSciences, Inc.
GLSI has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart GLSI
EBIT FORECAST
EBIT Forecast Chart GLSI
NET INCOME FORECAST
Net Income Chart GLSI